BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6176381)

  • 1. The current status and future prospects of treatment for multiple myeloma.
    Durie BG; Salmon SE
    Clin Haematol; 1982 Feb; 11(1):181-210. PubMed ID: 6176381
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing the complications of plasma cell myeloma.
    Cohen HJ; Rundles RW
    Arch Intern Med; 1975 Jan; 135(1):177-84. PubMed ID: 122891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
    Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
    Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Kahler's disease].
    Foa J; Carcassonne Y
    Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
    [No Abstract]   [Full Text] [Related]  

  • 5. Management and prognosis of multiple myeloma.
    Kyle RA; Elveback LR
    Mayo Clin Proc; 1976 Dec; 51(12):751-60. PubMed ID: 792581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
    Van Dobbenburgh OA; Houwen B; Piersma H; Marrink J; Ockhuizen T; Halie MR; Nieweg HO
    Neth J Med; 1984; 27(2):25-30. PubMed ID: 6709108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS; Volodiaeva EB; Fetisova EV; Pivnik AV; Margolin OV
    Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisone pulse therapy for refractory myeloma.
    Alexanian R; Yap BS; Bodey GP
    Blood; 1983 Sep; 62(3):572-7. PubMed ID: 6882916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclical chemotherapy of myeloma with cell synchronization: therapeutic trial. Apropos of 13 cases].
    Roux H; D'Omezon Y; Lagier C; Thouveny F; Recordier AM
    Rev Rhum Mal Osteoartic; 1976 Feb; 43(2):113-6. PubMed ID: 772787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of multiple myeloma.
    Malpas JS
    Br Med J; 1969 Apr; 2(5650):163-5. PubMed ID: 5778941
    [No Abstract]   [Full Text] [Related]  

  • 11. [Visceral calcinosis induced by intravenous phosphate perfusions in myelomatous hypercalcemia].
    Deshayes P; Levillain D; Cauvin M; Forthomme J
    Sem Hop; 1969 Feb; 45(7):444-9. PubMed ID: 4307115
    [No Abstract]   [Full Text] [Related]  

  • 12. Vindesine therapy in melphalan-resistant multiple myeloma.
    Houwen B; Ockhuizen T; Marrink J; Nieweg HO
    Eur J Cancer (1965); 1981 Feb; 17(2):227-32. PubMed ID: 7262159
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of chemotherapy in complex treatment of malignant bone tumors].
    Trapeznikov NN; Eremina LA
    Ter Arkh; 1977; 49(8):15-20. PubMed ID: 929386
    [No Abstract]   [Full Text] [Related]  

  • 14. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenbit D; Delbarre F
    Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudohypercalcemia and hyperviscosity with neurological manifestations in multiple myeloma.
    van Dijk JM; Sonnenblick M; Weissberg N; Rosin A
    Isr J Med Sci; 1986 Feb; 22(2):143-4. PubMed ID: 3753959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of malignant skeletal tumors (author's transl)].
    Brunner KW; Wagner HP
    Ther Umsch; 1979 Jul; 36(7):653-6. PubMed ID: 89708
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of skeletal metastases.
    Cadman E; Bertino JR
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1211-5. PubMed ID: 62744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of successive chemotherapy in multiple myeloma of bone. Prospective study over 4 years].
    Bataille R; Morlock G; Rosenberg F; Lopitaux R; Blotman F; Sany J; Ciurana AJ; Rampon S; Bussière JL; Simon L; Serre H
    Rev Rhum Mal Osteoartic; 1980 Feb; 47(2):77-82. PubMed ID: 7361063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of multiple myeloma. Review of the recent trials].
    Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
    Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.